Octapharma USA
Highly Engaged Employees
Highly Engaged EmployeesBlood & Organ Banks · New Jersey, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
121 River St Ste 1201, Hoboken, New Jers...Phone Number
(201) 604-1130Website
www.octapharmausa.comRevenue
$114.3 MillionIndustry
ZI Rank: 3
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
5
3
3
3
3
About Octapharma USA
Octapharma focuses on providing innovative health solutions by developing products that treat rare diseases and coagulopathies, as well as bleeding disorders. The company is dedicated to patient engagement and actively sponsors organizations worldwide to support communities. With a strong commitment to research and development, Octapharma is advancing human life through its plasma-based therapies. Its intended clients primarily include patients suffering from specific health conditions requiring specialized treatment.Explore more
Octapharma USA Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Octapharma USA your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Octapharma USA has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Octapharma USA launches new products
Earning: See what the market has to say on Octapharma USA recently announced quarterly report
Octapharma USA, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Octapharma USA had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Octapharma USA
Funding: Get notified immidiatlly once Octapharma USA has new funding data
Website visits: Recent activity has been detected on your website
Check out if Octapharma USA is spiking on competitors!
Recommended Actions
Find VP level buyers at Octapharma USA
Find 3 more new buyers
Compare Similar Companies to Octapharma USA
Compare insights from companies similar to Octapharma USA, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Octapharma USA is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Octapharma USA is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Octapharma USA.
Octapharma USA Tech Stack
A closer look at the technologies used by Octapharma USA
Most Recent Scoops
Hiring Plans
Octapharma USA has more open roles in Sales than it has had at any time in the past 6 months. Technologies mentioned include: Salesforce.
Hiring Plans
Hiring Plans
Octapharma USA has more open roles in Sales than it has had at any time in the past 12 months. Technologies mentioned include: Salesforce.
Hiring Plans
Hiring Plans
Octapharma USA has more open roles in Sales than it has had at any time in the past 12 months.
Hiring Plans
Person-Based
Person-Based
Octapharma USA News & Media
Octapharma USA Receives FDA Emergency Use Authorization for octaplasLG Powder, Allows U.S. Military Medical Providers Emergent Use in Treatment of Hemorrhage or Coagulopathy
PARAMUS, N.J., Aug. 20, 2024 /PRNewswire/ -- Octapharma USA has received U.S. Food and Drug Administration Emergency Use Authorization (EUA) for its proprietary octaplasLG Powder (blood group types A and AB). The EUA allows U.S. Department of Defense medical providers to administer the...Octapharma USA: JAMA Network Open Publishes Study Results Demonstrating Efficacy & Safety of Balfaxar® For Warfarin Reversal in Urgent Surgery & Invasive Procedures
PARAMUS, N.J., Aug. 13, 2024 /PRNewswire/ -- Octapharma USA announced the results from the Phase III (LEX-209) study on the efficacy and safety of Balfaxar® (prothrombin complex concentrate, human-lans; marketed in Europe and Canada as octaplex®) have been published by the JAMA Network...FDA Approves Additional Indication for Fibryga® for Fibrinogen Supplementation in Bleeding Patients with Acquired Fibrinogen Deficiency, Potentially Ushering in a New Standard of Care
PARAMUS, N.J, Aug. 1, 2024 /PRNewswire/ -- Octapharma USA, Inc. has announced the expanded approval of fibryga®, Fibrinogen (Human) Lyophilized Powder for Reconstitution, for fibrinogen replacement in bleeding patients with acquired fibrinogen deficiency (AFD) by the U.S. Food and Drug...Octapharma USA Appoints Biopharma Industry Veteran Kelly Hearn Vice President of Commercial Marketing & Development
Executive Brings More Than 20 Years of Pharmaceutical Experience Building Marketplace Leaders PARAMUS, N.J., May 20, 2024 /PRNewswire/ -- Octapharma USA, Inc. has appointed pharmaceutical industry veteran Kelly Hearn as Vice President of Commercial Development & Marketing, assuming...
Read more news
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Octapharma USA
Sign Up For FreeTo access detailed company insights
Octapharma focuses on providing innovative health solutions by developing products that treat rare diseases and coagulopathies, as well as bleeding disorders. The company is dedicated to patient engagement and actively sponsors organizations worldwide to support communities. With a strong commitment to research and development, Octapharma is advanc... Read More
